TDOC vs CRSP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TDOC Captures Institutional Edge (3โ1 Pillars ยท 3โ7 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Teladoc Health, Inc. (TDOC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CRSP counters with relative strength in Valuation. Fundamentally, TDOC trades at N/M Forward P/E with -5.4% operating margin (-3.4% YoY revenue) versus CRSP at 23.4x Forward P/E and -2058.6% operating margin (+1325.1% YoY). In options structure, TDOC sits in CONSOLIDATION (40th %ile IV; Dealer Gamma Walls on Pro) against CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TDOC Revenue | CRSP Revenue | TDOC Op. Margin | CRSP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $420M | $0M | -17.0% | -5087.8% | TDOC |
| FY2019 | $550M | $290M | -14.5% | 16.1% | CRSP |
| FY2020 | $1.09B | $0M | -46.3% | -49295.5% | TDOC |
| FY2021 | $2.03B | $910M | -13.1% | 40.8% | CRSP |
| FY2022 | $2.41B | $0M | -567.3% | -56190.4% | TDOC |
| FY2023 | $2.60B | $370M | -9.6% | -60.0% | TDOC |
| FY2024 | $2.57B | $40M | -39.7% | -1250.4% | TDOC |
| FY2025 | $2.53B | $0M | -10.4% | -18933.6% | TDOC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TDOC | CRSP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $4.1B | Larger Scale | CRSP |
| Trailing P/E Ratio Valuation | N/M | 23.4x | Lower Multiple | CRSP |
| Forward P/E Ratio Valuation | N/M | 23.4x | Lower Multiple | CRSP |
| Revenue Growth (YoY) Growth | -3.4% | +1325.1% | Higher Growth | CRSP |
| Operating Margin (TTM) Profitability | -5.4% | -2058.6% | Higher Margin | TDOC |
| Net Profit Margin Profitability | -6.3% | 0.0% | Higher Margin | CRSP |
| Return on Equity (ROE) Capital Efficiency | -11.5% | -25.6% | Higher ROE | TDOC |
| 52-Week Range Position Momentum | 76% ($4โ$10) | 1% ($40โ$63) | Stronger Trend | TDOC |
| Beta / 30D Volatility Risk Regime | 0.83ฮฒ ยท 108% Vol | 1.85ฮฒ ยท 60% Vol | Lower Realized Risk | CRSP |
| Unified Institutional Score Composite Signal | 43.8 / 100 (HOLD) | 44.7 / 100 (HOLD) | Higher Composite | CRSP |